Interferon-induced Protein-44 and Interferon-induced Protein 44-like restrict replication of Respiratory Syncytial Virus
File(s)Journal of Virology-2020-Busse-e00297-20.full.pdf (2.77 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Cellular intrinsic immunity, mediated by the expression of an array of interferon-stimulated antiviral genes, is a vital part of host defence. We have previously used a bioinformatic screen to identify two interferon stimulated genes (ISG) with poorly characterised function, Interferon-induced protein 44 (IFI44) and interferon-induced protein 44-like (IFI44L), as potentially being important in Respiratory Syncytial Virus (RSV) infection. Using overexpression systems, CRISPR-Cas9-mediated knockout, and a knockout mouse model we investigated the antiviral capability of these genes in the control of RSV replication. Over-expression of IFI44 or IFI44L was sufficient to restrict RSV infection at an early time post infection. Knocking out these genes in mammalian airway epithelial cells increased levels of infection. Both genes express antiproliferative factors that have no effect on RSV attachment but reduce RSV replication in a minigenome assay. The loss of Ifi44 was associated with a more severe infection phenotype in a mouse model of infection. These studies demonstrate a function for IFI44 and IFI44L in controlling RSV infection.
Date Issued
2020-09
Date Acceptance
2020-06-23
Citation
Journal of Virology, 2020, 94 (18), pp.1-15
ISSN
0022-538X
Publisher
American Society for Microbiology
Start Page
1
End Page
15
Journal / Book Title
Journal of Virology
Volume
94
Issue
18
Copyright Statement
© 2020 Busse et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
License URL
Sponsor
Wellcome Trust
Commission of the European Communities
European Commission
European Commission
Wellcome Trust
National Institutes of Health USA
Imperial College Healthcare NHS Trust- BRC Funding
Imperial College London
Identifier
https://jvi.asm.org/content/94/18/e00297-20
Grant Number
109056/Z/15/Z
279185
279185
Horizon 2020
RSRO_54990
National Institutes of Health USA
RDA02
Subjects
IFI44
RSV
innate immunity
intrinsic immunity
restriction factor
06 Biological Sciences
07 Agricultural and Veterinary Sciences
11 Medical and Health Sciences
Virology
Publication Status
Published
Date Publish Online
2020-08-31